In contrast, Hodgkin's lymphoma HLDM-2 cells, breast cancer MDA-MB-468 cells and prostate cancer DU145 cells exhibited high levels of phospho-JAK1 and -JAK2 but not phospho-JAK3 (Figure 5B-D). This evidence concerns the gene JAK3 and Hodgkins lymphoma.